GliaPharm is a Swiss biotechnology company that focuses on developing treatments for neurological and psychiatric disorders by targeting glial cells. Their innovative approach aims to sustain and enhance brain metabolism in pathological conditions. The company's vision is to become a leader in developing glial cell targeting agents that act as neuroprotective agents and maintain cognitive function...